Literature DB >> 25314917

Red blood cell generation by three-dimensional aggregate cultivation of late erythroblasts.

EunMi Lee1, So Yeon Han, Hye Sook Choi, Bokhwan Chun, Byunghee Hwang, Eun Jung Baek.   

Abstract

Stem cell-derived erythroid cells hold great potential for the treatment of blood-loss anemia and for erythropoiesis research; however, cultures using conventional flat plates or bioreactors have failed to show promising results. By mimicking the in vivo bone marrow (BM) environment in which most erythroid cells are physically aggregated, we show that a three-dimensional (3D) aggregate culture system facilitates erythroid cell maturation and red blood cell (RBC) production more effectively than two-dimensional high-density cell cultivation. Late erythroblasts (polychromatic or orthochromatic erythroblasts) were differentiated from cord blood CD34(+) cells over 15 days and then allowed to form tight aggregates at a minimum density of 1×10(7) cells/mL for 2-3 days. To scale up the cell culture and to make the media supply efficient throughout the cell aggregates, several macroporous microcarriers and porous scaffolds were applied to the 3D culture system. In comparison to control culture conditions, erythroid cells in 3D aggregates were significantly more differentiated toward RBCs with significantly reduced nuclear dysplasia. When 3D culture was performed inside macroporous microcarriers, the cell culture scale was increased and cells exhibited enhanced differentiation and enucleation. Microcarriers with a pore diameter of approximately 400 μm produced more mature cells than those with a smaller pore diameter. In addition, this aggregate culture method minimized the culture space and media volume required. In conclusion, a 3D aggregate culture system can be used to generate transfusable human erythrocytes at the terminal maturation stage, mimicking the in vivo BM microenvironment. Porous structures can efficiently maximize the culture scale, enabling large-scale production of RBCs. These results enhance our understanding of the importance of physical contact among late erythroblasts for their final maturation into RBCs.

Entities:  

Mesh:

Year:  2015        PMID: 25314917      PMCID: PMC4333638          DOI: 10.1089/ten.TEA.2014.0325

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  12 in total

1.  Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells.

Authors:  Greggory J Housler; Toshio Miki; Eva Schmelzer; Christopher Pekor; Xiaokui Zhang; Lin Kang; Vanessa Voskinarian-Berse; Stewart Abbot; Katrin Zeilinger; Jörg C Gerlach
Journal:  Tissue Eng Part C Methods       Date:  2011-12-28       Impact factor: 3.056

2.  Enhanced production of red blood cells in suspension by electrostatic interactions with culture plates.

Authors:  Eun Jung Baek; Jungmok You; Min Sun Kim; So-Young Lee; Seong-Je Cho; Eunkyoung Kim; Hyun Ok Kim
Journal:  Tissue Eng Part C Methods       Date:  2010-04-20       Impact factor: 3.056

Review 3.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

4.  Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system.

Authors:  P C Collins; L K Nielsen; S D Patel; E T Papoutsakis; W M Miller
Journal:  Biotechnol Prog       Date:  1998 May-Jun

5.  Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells.

Authors:  Nicholas E Timmins; Stavrosia Athanasas; Marko Günther; Penelope Buntine; Lars K Nielsen
Journal:  Tissue Eng Part C Methods       Date:  2011-09-08       Impact factor: 3.056

Review 6.  Manufactured RBC--rivers of blood, or an oasis in the desert?

Authors:  N E Timmins; L K Nielsen
Journal:  Biotechnol Adv       Date:  2011-05-14       Impact factor: 14.227

7.  The effect of mild agitation on in vitro erythroid development.

Authors:  Daniela Boehm; William G Murphy; Mohamed Al-Rubeai
Journal:  J Immunol Methods       Date:  2010-06-10       Impact factor: 2.303

8.  Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer.

Authors:  Eun Jung Baek; Han-Soo Kim; Ju-Hye Kim; Nahn Ju Kim; Hyun Ok Kim
Journal:  Transfusion       Date:  2009-07-10       Impact factor: 3.157

9.  Dynamics of human erythroblast enucleation.

Authors:  Miwa Hebiguchi; Makoto Hirokawa; Yong-Mei Guo; Kunie Saito; Hideki Wakui; Atsushi Komatsuda; Naohito Fujishima; Naoto Takahashi; Tsutomu Takahashi; Takehiko Sasaki; Wataru Nunomura; Yuichi Takakuwa; Kenichi Sawada
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

10.  Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.

Authors:  Ryo Kurita; Noriko Suda; Kazuhiro Sudo; Kenichi Miharada; Takashi Hiroyama; Hiroyuki Miyoshi; Kenzaburo Tani; Yukio Nakamura
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more
  4 in total

1.  Long-Term Human Hematopoietic Stem Cell Culture in Microdroplets.

Authors:  Pilar Carreras; Itziar González; Miguel Gallardo; Alejandra Ortiz-Ruiz; Maria Luz Morales; Jessica Encinas; Joaquín Martínez-López
Journal:  Micromachines (Basel)       Date:  2021-01-16       Impact factor: 2.891

2.  Latest culture techniques: cracking the secrets of bone marrow to mass-produce erythrocytes and platelets ex vivo.

Authors:  Christian A Di Buduo; Alicia Aguilar; Paolo M Soprano; Alberto Bocconi; Carolina P Miguel; Giovanna Mantica; Alessandra Balduini
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

3.  Polyurethane scaffolds seeded with CD34(+) cells maintain early stem cells whilst also facilitating prolonged egress of haematopoietic progenitors.

Authors:  Charlotte E Severn; Hugo Macedo; Mark J Eagle; Paul Rooney; Athanasios Mantalaris; Ashley M Toye
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

4.  Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.

Authors:  So Yeon Han; Eun Mi Lee; Suyeon Kim; Amy M Kwon; Eun Jung Baek
Journal:  Int J Mol Sci       Date:  2020-09-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.